CTSL and major depressive disorder: In the validation cohort, analyzed by qPCR, we observed a decreasing trend in the levels of CTSL and TRPV2 in MDD patients and an increasing trend in ZNF713, which was consistent with the transcriptomic results (Figure 6g).